Volume 24, Number 9—September 2018
Case Report and Genetic Sequence Analysis of Candidatus Borrelia kalaharica, Southern Africa
Views: Views equals page views plus PDF downloadsMetric Details
Highlight and copy the desired format.
|EID||Stete K, Rieg S, Margos G, Häcker G, Wagner D, Kern WV, et al. Case Report and Genetic Sequence Analysis of Candidatus Borrelia kalaharica, Southern Africa. Emerg Infect Dis. 2018;24(9):1659-1664. https://dx.doi.org/10.3201/eid2409.171381|
|AMA||Stete K, Rieg S, Margos G, et al. Case Report and Genetic Sequence Analysis of Candidatus Borrelia kalaharica, Southern Africa. Emerging Infectious Diseases. 2018;24(9):1659-1664. doi:10.3201/eid2409.171381.|
|APA||Stete, K., Rieg, S., Margos, G., Häcker, G., Wagner, D., Kern, W. V....Fingerle, V. (2018). Case Report and Genetic Sequence Analysis of Candidatus Borrelia kalaharica, Southern Africa. Emerging Infectious Diseases, 24(9), 1659-1664. https://dx.doi.org/10.3201/eid2409.171381.|
Tickborne relapsing fever caused by Borrelia species is rarely reported in travelers returning from Africa. We report a case of a 71-year-old woman who sought treatment at University Medical Center in Freiburg, Germany, in 2015 with recurrent fever after traveling to southern Africa. We detected spirochetes in Giemsa-stained blood smears. Treatment with doxycycline for suspected tickborne relapsing fever was successful. Sequence analyses of several loci (16S rRNA, flagellin, uvrA) showed high similarity to the recently described Candidatus Borrelia kalaharica, which was found in a traveler returning from the same region earlier that year. We provide additional information regarding the genetic relationship of Candidatus B. kalaharica. Sequence information for an additional 6 housekeeping genes enables improved comparability to other borrelial species that cause relapsing fever. Our report underlines the importance and possible emergence of the only recently delineated pathogen in southern Africa.
An infection with Borrelia species bacteria causes relapsing fever (RF). It is transmitted by several arthropods, and dependent on the transmitting vector; louseborne relapsing fever (LBRF) is different from tickborne relapsing fever (TBRF) (1,2). The clinical picture of RF includes recurrent fever episodes accompanied by headache, hepatomegaly, splenomegaly, vomiting, conjunctivitis, myalgia, and arthralgia. It may be difficult to differentiate RF from other febrile illnesses, especially malaria. RF can be diagnosed by detection of spirochetes in blood smears or by PCR of EDTA-blood, and treatment is typically with penicillins or tetracyclines (1,3).
Whereas B. recurrentis is the cause of LBRF, which occurs mainly in the Horn of Africa, several Borrelia species may cause TBRF, which is found in many areas of the world. The endemic Borrelia species differ across geographic regions, and they have traditionally been divided into Old World and New World Borrelia. So far, ≈15 Borrelia species have been described to cause TBRF in humans worldwide (1). In Africa, TBRF has been traditionally attributed to B. crocidurae in western Africa, B. hispanica in northern Africa, and B. duttonii in eastern Africa (1,4).
Because microscopy is currently the standard method for diagnosis of TBRF in most countries in Africa, diagnosis does not usually include differentiation of species. With the advent of molecular diagnostic methods, scientists can identify species by sequencing different loci of Borrelia DNA from blood, such as the 16S rRNA gene, the flagellin gene (flaB), or the glpQ gene (5,6). Sequence analysis has challenged the assumption of strict division of species across Africa not only by the detection of geographic overlap of several Borrelia species, but also by detection of previously unknown species (6). Moreover, a Borrelia species found in ticks and in human blood in Tanzania showed more homology to New World Borrelia species than to the species known to be present in Africa (7–9). These findings were based on 16S rRNA and flaB partial sequences, which were deposited in GenBank as B. duttonii (accession nos. AB113315, AB105169, AB105132, AB057547, and AB105118). In 2015, a case of RF was described in a German tourist after traveling to the Kalahari Desert. The strain also showed greater genetic homology to New World Borrelia spp. and was proposed as a new species Candidatus B. kalaharica on the basis of the analysis of 16S rRNA, flaB, and uvrA genes (10).
Although RF is believed to be endemic to many areas in Africa, it is rarely diagnosed in travelers returning from these regions (11). In previous years, several cases of LBRF have been reported from several countries in Europe in migrants from eastern Africa (2,3,12–16). Reports on TBRF in travelers returning from Africa to Europe are limited to case reports. Most of these infections were acquired in West Africa (17–23), with single reports from other areas, such as Ethiopia and Morocco (21,24).
We present a case of TBRF in a tourist from Germany returning from southern Africa and describe the results of a comprehensive molecular diagnostic analysis that underlines that Candidatus B. kalaharica represents a new species that is genetically distant from other RF group species and that it appears to be an emerging pathogen for humans that should be considered in the differential diagnosis of febrile patients. We obtained written informed consent from the patient for publication.
We performed slide microscopy after standard Giemsa staining of a thick and a thin blood smear. We obtained photographs from a 100× magnification objective using a Nikon Eclipse Ni microscope (Nikon Corporation, Tokyo, Japan).
We initiated in vitro cultures of infected blood using medium and conditions as previously described for RF species (25,26). We performed DNA extraction from EDTA blood using the Maxwell 16 FFS Nucleic Acid Extraction System Custom Kit (Promega, Mannheim, Germany) according to the manufacturer’s instructions. We amplified fragments of the 16S rRNA, glpQ and flaB using primers and PCR conditions as described previously (25,27,28). We performed multilocus sequence analysis (MLSA) on housekeeping genes (clpA, clpX, nifS, pepX, pyrG, rplB, recG, and uvrA) as described (29; Technical Appendix Table 1). For PCR we ran HotStarTaq Mastermix (QIAGEN, Hilden, Germany) as touch-down protocol for the first 9 cycles with annealing temperatures of 55°C–48°C, decreasing 1°C each cycle, followed by 32 cycles at 48°C annealing temperature. The temperature profile was 95°C for 15 min for activation of Taq polymerase, 94°C for 30 s for denaturation, 30 s for annealing at the temperatures given previously, and 72°C for 60 s for elongation. A final step of elongation was at 72°C for 5 min, and then we held the samples at 12°C.
We used GATC Biotech AG (Konstanz, Germany) for sequencing, and performed sequence alignment, genetic distance analyses, and construction of phylogenetic trees in MEGA5 (30,31). We used BLAST (32) to compare the sequences we obtained (GenBank accession nos. KY560340–8) to sequences in GenBank (accession numbers in Technical Appendix Tables 2, 4) using standard settings. We conducted genetic distance analyses in MEGA5 (31) using the Kimura 2-parameter model (30). We inferred the evolutionary history by using the maximum likelihood method based on the general time-reversible model (33). We generated the initial trees for the heuristic search automatically by applying neighbor-joining and BioNJ algorithms to a matrix of pairwise distances estimated using the maximum composite likelihood approach, and then selecting the topology with superior log likelihood value. We calculated node support values with 1,000 bootstrap repeats. We used discrete gamma distribution to model evolutionary rate differences among sites [+G]. The rate variation model allowed for some sites to be evolutionarily invariable [+I]. The trees are drawn to scale, with branch lengths measured in the number of substitutions per site. Codon positions included were 1st + 2nd + 3rd + noncoding for flaB sequences and housekeeping gene sequences. We eliminated all positions containing gaps and missing data.
A 71-year old woman sought treatment for fever after a 4-week camping trip to South Africa, Namibia, Botswana, and Zimbabwe. The patient reported no malaria chemoprophylaxis, fresh water contact, or tick bites. Other than horseback riding, she could recall no direct contact with animals. Preexisting conditions were nonmetastatic breast cancer under treatment with exemestan and a history of penicillin allergy.
The patient reported fever episodes starting 3 days before returning to Germany. Malaria was ruled out at a local health unit in South Africa by thick smear microscopy. Three days after arriving in Germany, the patient came to our clinic with a history of fever but no other abnormal signs or symptoms. Leukocyte counts were normal; levels of C-reactive protein and procalcitonin were slightly elevated (Figure 1). A malaria thick blood smear, blood cultures, and a dengue nonstructural protein 1 antigen test showed negative results. The fever resolved spontaneously, and the patient was discharged and asked to return in case of recurrence of symptoms.
Seventeen days later, the patient returned with RF (temperature >39°C). She reported 2 episodes of fever lasting 2–3 days flanked by symptom-free intervals of ≈4 days (Figure 1). Leukocyte counts again were normal; and levels of C-reactive protein and procalcitonin were elevated. We detected no malaria parasites in a thick smear; however, we found multiple spirochetes compatible with Borrelia species (Figure 2). We made a presumptive diagnosis of TBRF on the basis of the travel route and with no evidence of body lice infestation. We started antimicrobial therapy with doxycycline (2 × 100 mg/d) and close monitoring. We observed no signs of a Herxheimer reaction. PCR diagnostics of 16S rRNA confirmed the diagnosis of Borrelia infection. For further species differentiation, we sent a blood sample to the German National Reference Center for sequence analysis for Borrelia. An 11-day course of doxycycline led to an uneventful recovery with no recurrence of fever.
Sequence Analysis and Phylogeny
To investigate the Borrelia species designation, we conducted BLAST searches using the 16S rRNA PCR fragment. Top hits included Candidatus B. kalaharica, B. duttonii strain VS4, B. turicatae, and B. parkeri. Genetic distance analyses using the 16S rRNA fragments in MEGA5 (31) revealed strains Candidatus B. kalaharica (10) and VS4 from Tanzania, an atypical RF strain present in the Old World (8), as closest matches (Technical Appendix Table 2). Although designated B. duttonii in GenBank, VS4 was closely related to some strains found in the Mvumi region of Tanzania (7) which were shown to be more closely related to New World RF species than to B. duttonii. Genetic distance values obtained for the 16S rRNA fragment were 0.2% for Candidatus B. kalaharica and slightly higher for B. parkeri, B. crocidurae, and B. turicatae (0.4%) (Technical Appendix Table 2).
When the sequence of a flagellin gene (flaB) fragment (252 bp) was used for genetic distance analysis, Candidatus B. kalaharica was again the most closely related strain, with genetic distance value = 0.000 (Technical Appendix Table 3). Strains representing atypical B. duttonii (7,8) showed higher genetic distance values (strain TnB, 0.8%; strain EM14, 1.2%), whereas for other Borrelia species such as B. anserina BA2 (5.8%), B. turicatae (6.2%) and B. parkeri (6.2%), the values were even higher, indicating a close genetic relationship of the strain investigated here to Ca. B. kalaharica. This was also reflected in phylogenies (Technical Appendix Figures 1, 2). In the 16S rRNA phylogeny, the DNA isolate investigated here formed a clade together with Candidatus B. kalaharica and VS4 from Mvumi, Tanzania (8,10). In the flaB phylogeny, our DNA isolate and Candidatus B. kalaharica formed a sister clade to strains from the Mvumi region in Tanzania (7,8), notably outside the clade containing Old World RF species such as B. duttonii, suggesting that they are divergent from B. duttonii.
We obtained similar results using 7 housekeeping loci (Figure 3; Technical Appendix Tables 4, 5) and, in particular locus uvrA. For this locus, sequences of Candidatus B. kalaharica were available (Figure 3, panel A). Genetic distance analysis (Technical Appendix Tables 4, 5) and phylogenetic inferences (Figure 3, panel B) further support the close genetic relationship of the specimen investigated here with Ca. B. kalaharica and both clusters next to B. anserina. For MLST analysis, only 7 genes could be included as clpA PCR did not yield a PCR product. The PCR for the glpQ locus also proved negative in spite of several amplification attempts suggesting that perhaps base differences in the primer regions prevented amplification. Despite our efforts, we were unable to cultivate the causative pathogen from blood.
The case described here is the second report within a few months of TBRF in a tourist from Germany traveling to countries in southern Africa, such as South Africa, Namibia, and Botswana (10). In the previous case, a presumed soft tick bite in the Kalahari Desert was described, whereas our patient did not report any arthropod bite. However, contact with arthropods was likely as the patient was camping. Soft tick Ornithodoros species only need short blood meals and do not attach tightly to the host (34), making it conceivable that a feeding tick was not noticed. These cases underscore that, in returning travelers with RF, TBRF should be considered in the differential diagnosis, even if no tick bite is reported. Thick smears are the diagnostic procedure of choice and should be carefully evaluated for corkscrew-shaped spirochetes (1). However, the sensitivity of this method may change depending on febrile versus afebrile periods with different pathogen loads circulating in the blood. Thus, as we saw in this patient, thick smears may turn negative during infection and should therefore be repeated preferentially during febrile episodes.
Death as a result of TBRF is considered to be rare; however, higher mortality rates have been suspected as a result of Herxheimer reactions, even though there is a lack of data for TBRF in Africa (1,35). Clinicians need to be aware that the initiation of antimicrobial treatment might be associated with a severe Herxheimer reaction, necessitating aggressive supportive care.
Borrelia species can be identified and differentiated by means of DNA sequence analysis, although it may be hard to distinguish closely related Borrelia species, such as B. duttonii, B. recurrentis, and B. crocidurae (36,37). 16S rRNA sequences are available for many of the Borrelia species and strains that have been found in Africa and thus, although the locus may have low resolution, it can give a first indication of relationships. Other loci that have been used in previous reports were also used in the current study, including flaB and housekeeping loci (37). Because there is so little information about which RF-causing species do occur in southern Africa (6), a more thorough characterization of the DNA isolate would be beneficial to epidemiologists and other researchers in the field.
The traditional concept of strict division of geographic areas into Old World and New World Borrelia and division of species across Africa has been challenged by the description of new Borrelia species. This is the second report of a species that has not been described previously. Genetically, Candidatus B. kalaharica is most closely related to TBRF Borrelia described from the Mvumi region in Tanzania (8,38). In previous publications it was suggested that these Borrelia strains from Mvumi may belong to the new species (8,38). Unfortunately, the only available sequences were for 16S rRNA and flaB, but more sequence data will be needed to reveal the taxonomic position of these strains. Of interest, both the strains from Mvumi and Candidatus B. kalaharica show more genetic similarity to New World RF species than to the expected Old World species.
We report the second case of a human infection with the proposed new species Candidatus B. kalaharica. Our findings support the definition of Candidatus B. kalaharica as a new species that is genetically distant from other RF group species and more closely related to New World RF Borreliae. It appears to be an emerging pathogen for humans that should be considered in the differential diagnosis of febrile patients.
Dr. Stete is a resident in internal medicine and infectious diseases at the Division of Infectious Diseases, University Medical Center, Freiburg, Germany. Her primary research interests are in the field of parasitic diseases, travel medicine, and migration health.
We thank the patient for providing consent to publish this case.
- Cutler SJ, Abdissa A, Trape J-F. New concepts for the old challenge of African relapsing fever borreliosis. Clin Microbiol Infect. 2009;15:400–6.
- Seilmaier M, Guggemos W, Wieser A, Fingerle V, Balzer L, Fenzl T, et al. [Louse-borne-relapsing-fever in refugees from the Horn of Africa; a case series of 25 patients] [in German]. Dtsch Med Wochenschr. 2016;141:e133–42.
- Hoch M, Wieser A, Löscher T, Margos G, Pürner F, Zühl J, et al. Louse-borne relapsing fever (Borrelia recurrentis) diagnosed in 15 refugees from northeast Africa: epidemiology and preventive control measures, Bavaria, Germany, July to October 2015. Euro Surveill. 2015;20:30046.
- Elbir H, Henry M, Diatta G, Mediannikov O, Sokhna C, Tall A, et al. Multiplex real-time PCR diagnostic of relapsing fevers in Africa. PLoS Negl Trop Dis. 2013;7:e2042.
- Fukunaga M, Okada K, Nakao M, Konishi T, Sato Y. Phylogenetic analysis of Borrelia species based on flagellin gene sequences and its application for molecular typing of Lyme disease borreliae. Int J Syst Bacteriol. 1996;46:898–905.
- Elbir H, Raoult D, Drancourt M. Relapsing fever borreliae in Africa. Am J Trop Med Hyg. 2013;89:288–92.
- Kisinza WN, McCall PJ, Mitani H, Talbert A, Fukunaga M. A newly identified tick-borne Borrelia species and relapsing fever in Tanzania. Lancet. 2003;362:1283–4.
- Mitani H, Talbert A, Fukunaga M. New World relapsing fever Borrelia found in Ornithodoros porcinus ticks in central Tanzania. Microbiol Immunol. 2004;48:501–5.
- Scott JC, Wright DJM, Cutler SJ. Typing African relapsing fever spirochetes. Emerg Infect Dis. 2005;11:1722–9.
- Fingerle V, Pritsch M, Wächtler M, Margos G, Ruske S, Jung J, et al. “Candidatus Borrelia kalaharica” detected from a febrile traveller returning to Germany from vacation in southern Africa. PLoS Negl Trop Dis. 2016;10:e0004559.
- Rebaudet S, Parola P. Epidemiology of relapsing fever borreliosis in Europe. FEMS Immunol Med Microbiol. 2006;48:11–5.
- Antinori S, Mediannikov O, Corbellino M, Raoult D. Louse-borne relapsing fever among East African refugees in Europe. Travel Med Infect Dis. 2016;14:110–4.
- Wilting KR, Stienstra Y, Sinha B, Braks M, Cornish D, Grundmann H. Louse-borne relapsing fever (Borrelia recurrentis) in asylum seekers from Eritrea, the Netherlands, July 2015. Euro Surveill. 2015;20:21196.
- Osthoff M, Schibli A, Fadini D, Lardelli P, Goldenberger D. Louse-borne relapsing fever - report of four cases in Switzerland, June-December 2015. BMC Infect Dis. 2016;16:210.
- Ciervo A, Mancini F, di Bernardo F, Giammanco A, Vitale G, Dones P, et al. Louseborne relapsing fever in young migrants, Sicily, Italy, July–September 2015. Emerg Infect Dis. 2016;22:152–3.
- Lucchini A, Lipani F, Costa C, Scarvaglieri M, Balbiano R, Carosella S, et al. Louseborne relapsing fever among East African refugees, Italy, 2015. Emerg Infect Dis. 2016;22:298–301.
- Colebunders R, De Serrano P, Van Gompel A, Wynants H, Blot K, Van den Enden E, et al. Imported relapsing fever in European tourists. Scand J Infect Dis. 1993;25:533–6.
- Chatel G, Gulletta M, Matteelli A, Marangoni A, Signorini L, Oladeji O, et al. Short report: Diagnosis of tick-borne relapsing fever by the quantitative buffy coat fluorescence method. Am J Trop Med Hyg. 1999;60:738–9.
- Gallien S, Sarfati C, Haas L, Lagrange-Xelot M, Molina JM. Borreliosis: a rare and alternative diagnosis in travellers’ febrile illness. Travel Med Infect Dis. 2007;5:247–50.
- Million M, Cazorla C, Doudier B, La Scola B, Parola P, Drancourt M, et al. Molecular identification of Borrelia crocidurae in a patient returning from Senegal. BMJ Case Rep. 2009;2009: pii:bcr06.2008.0298. http://casereports.bmj.com/content/2009/bcr.06.2008.0298
- Wyplosz B, Mihaila-Amrouche L, Baixench M-T, Bigel M-L, Berardi-Grassias L, Fontaine C, et al. Imported tickborne relapsing fever, France. Emerg Infect Dis. 2005;11:1801–3.
- Tordini G, Giaccherini R, Corbisiero R, Zanelli G. Relapsing fever in a traveller from Senegal: determination of Borrelia species using molecular methods. Trans R Soc Trop Med Hyg. 2006;100:992–4.
- van Dam AP, van Gool T, Wetsteyn JC, Dankert J. Tick-borne relapsing fever imported from West Africa: diagnosis by quantitative buffy coat analysis and in vitro culture of Borrelia crocidurae. J Clin Microbiol. 1999;37:2027–30.
- Socolovschi C, Honnorat E, Consigny PH, Dougados J, Passeron A, Parola P, et al. Tick-borne relapsing fever with cutaneous eschar and radiculopathy, Ethiopia. J Travel Med. 2012;19:261–3.
- Margos G, Stockmeier S, Hizo-Teufel C, Hepner S, Fish D, Dautel H, et al. Long-term in vitro cultivation of Borrelia miyamotoi. Ticks Tick Borne Dis. 2015;6:181–4.
- Marosevic D, Margos G, Wallich R, Wieser A, Sing A, Fingerle V. First insights in the variability of Borrelia recurrentis genomes. PLoS Negl Trop Dis. 2017;11:e0005865.
- Assous MV, Wilamowski A, Bercovier H, Marva E. Molecular characterization of tickborne relapsing fever Borrelia, Israel. Emerg Infect Dis. 2006;12:1740–3.
- Venczel R, Knoke L, Pavlovic M, Dzaferovic E, Vaculova T, Silaghi C, et al. A novel duplex real-time PCR permits simultaneous detection and differentiation of Borrelia miyamotoi and Borrelia burgdorferi sensu lato. Infection. 2016;44:47–55.
- Jolley KA, Maiden MCJ. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics. 2010;11:595.
- Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980;16:111–20.
- Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28:2731–9.
- Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215:403–10.
- Nei M, Kumar S. Molecular evolution and phylogenetics. New York: Oxford University Press, Inc; 2000.
- Boyle WK, Wilder HK, Lawrence AM, Lopez JE. Transmission dynamics of Borrelia turicatae from the arthropod vector. PLoS Negl Trop Dis. 2014;8:e2767.
- Dworkin MS, Anderson DE Jr, Schwan TG, Shoemaker PC, Banerjee SN, Kassen BO, et al. Tick-borne relapsing fever in the northwestern United States and southwestern Canada. Clin Infect Dis. 1998;26:122–31.
- Elbir H, Gimenez G, Sokhna C, Bilcha KD, Ali J, Barker SC, et al. Multispacer sequence typing relapsing fever Borreliae in Africa. PLoS Negl Trop Dis. 2012;6:e1652.
- Fotso Fotso A, Drancourt M. Laboratory diagnosis of tick-borne African relapsing fevers: latest developments. Front Public Health. 2015;3:254.
- Cutler SJ, Ruzic-Sabljic E, Potkonjak A. Emerging borreliae - Expanding beyond Lyme borreliosis. Mol Cell Probes. 2017;31:22–7.
FiguresCite This Article
Original Publication Date: 7/23/2018
1These authors contributed equally to this article.
- Page created: August 14, 2018
- Page last updated: August 14, 2018
- Page last reviewed: August 14, 2018
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)